• eDrugstore facebook
  • eDrugstore twitter
  • eDrugstore instagram
  • eDrugstore youtube
  • eDrugstore wordpress
  • eDrugstore reddit
  • eDrugstore tiktok
  • eDrugstore User
Buy BIMATOPROST

-

Womens Health

Mfg : Micro Labs
In-Stock

Bimatoprost - Generic Latisse

Generic Prescription Eyelash Growth Treatment Contains bimatoprost 0.03% for promoting longer, thicker, darker eyelashes.

Generic Equivalent to Latisse® Contains bimatoprost 0.03%, the same active ingredient as the branded eyelash growth treatment.

Eyelash Growth Promotion Clinically shown to enhance eyelash length, thickness, and darkness by prolonging the growth phase of the hair cycle.

Prescription Required Available only with a valid prescription from a licensed healthcare provider following appropriate medical evaluation.

Topical Ophthalmic Application Once-daily application to upper eyelid margin using sterile, single-use applicators provided with the treatment.

Disclaimer: The FDA may not have evaluated this product for safety, effectiveness, or quality.
*Sold in single pill quantities

Product as described

Your saving $ 00.00

Per Dose $ 00.00

Total Price

$ 00.00
Add To Cart
See all prices

Real Stories, Real Results

Prescription Treatment for Eyelash Enhancement

Bimatoprost 0.03% is a generic prescription medication containing the same active ingredient as brand-name Latisse®. This ophthalmic solution is specifically formulated to address inadequate or insufficient eyelashes by promoting growth, increasing length, thickness, and darkness of natural lashes.

When applied as directed along the base of the upper eyelashes, bimatoprost works by prolonging the growth phase of the eyelash hair cycle. Results are gradual and progressive, with noticeable improvement typically seen within 4-8 weeks of consistent use, and full results after approximately 16 weeks of nightly application.

IMPORTANT SAFETY INFORMATION: This is a prescription medication that requires proper medical evaluation and supervision. Do not use without consultation and prescription from a healthcare provider. It is specifically indicated for eyelash growth and should only be used as directed.

Key Treatment Features:

  • Same Active Ingredient: Contains bimatoprost 0.03%, identical to the branded formulation
  • Progressive Results: Gradual improvement over weeks of consistent use
  • Clinical Support: Demonstrated effectiveness in promoting eyelash growth
  • Simple Application: Once-daily application to upper eyelid margin
  • Maintenance Required: Continued use needed to maintain results

Proper Usage Guidelines:

  1. Clean Application: Start with clean face and remove makeup
  2. Precise Placement: Apply one drop to sterile applicator, then along skin of upper eyelid at base of lashes
  3. Avoid Contamination: Do not allow applicator tip to contact any surface
  4. Single Use: Use each applicator once only, then discard
  5. Nightly Routine: Apply once daily, typically in the evening

Important Safety Considerations:

  • Eye Health: May cause eye irritation, redness, or darkening of eyelid skin
  • Permanent Changes: Iris pigmentation changes may be permanent
  • Contact Lens Use: Remove contact lenses before application may reinsert after 15 minutes
  • Medical History: Inform your doctor of eye conditions, infections, or inflammation
  • Pregnancy/Breastfeeding: Consult your doctor if pregnant, planning pregnancy, or breastfeeding

Potential Side Effects: Common side effects may include itchy eyes, eye redness, dry eyes, or eyelid skin darkening. Serious but rare side effects can include eye infections, vision changes, or severe allergic reactions. Discontinue use and consult your doctor if eye irritation or infection occurs.

This information is for educational purposes only. Always consult with a qualified healthcare professional for proper diagnosis, prescription, and treatment guidance.

;
This website uses cookies to improve functionality, analyze performance, and deliver personalized content. Some data, including sensitive health-related information, may be shared with authorized partners for analytics and advertising.